The latest closing stock price for Zevra Therapeutics as of July 29, 2025 is 10.81.
An investor who bought $1,000 worth of Zevra Therapeutics stock at the IPO in 2015 would have $-940 today, roughly -1 times their original investment - a -24.48% compound annual growth rate over 10 years.
The all-time high Zevra Therapeutics stock closing price was 378.08 on September 18, 2015.
The Zevra Therapeutics 52-week high stock price is 13.16, which is 21.7% above the current share price.
The Zevra Therapeutics 52-week low stock price is 6.10, which is 43.6% below the current share price.
The average Zevra Therapeutics stock price for the last 52 weeks is 8.32.
An investor who bought $1,000 worth of Zevra Therapeutics stock at the IPO in 2015 would have $-940 today, roughly -1 times their original investment - a -24.48% compound annual growth rate over 10 years.
The all-time high Zevra Therapeutics stock closing price was 378.08 on September 18, 2015.
The Zevra Therapeutics 52-week high stock price is 13.16, which is 21.7% above the current share price.
The Zevra Therapeutics 52-week low stock price is 6.10, which is 43.6% below the current share price.
The average Zevra Therapeutics stock price for the last 52 weeks is 8.32.